Audited Results of Lincoln Pharmaceuticals Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	671.03	623.23	580.55	510.31	472.08
Manufacturing Expenses	0	11.66	11.47	10.25	8.33
Personnel Expenses	125.19	112.45	102.90	93.16	70.47
Selling Expenses	0	2.67	1.03	1.16	0.06
Administrative Expenses	137	102.31	85.22	73.48	77.96
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	573.35	521.74	480.64	421.14	376.61
Operating Profit	97.68	101.49	99.91	89.17	95.47
Other Recurring Income	33.45	22.48	34.42	22.48	10
Adjusted PBDIT	131.14	123.97	134.33	111.65	105.47
Financial Expenses	1.01	1.88	1.46	2.03	1.45
Depreciation	14.50	12.90	10.62	9.17	8.09
Other Write offs	0	0	0	0	0
Adjusted PBT	115.62	109.19	122.24	100.46	95.93
Tax Charges	27.73	26.84	28.94	27.56	26.57
Adjusted PAT	87.89	82.35	93.30	72.90	69.36
Non Recurring Items	0	0	0	-0.48	0.13
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	87.89	82.35	93.30	72.90	69.36
Equity Dividend	0	3.61	3	3	3
Preference Dividend	0	0	0	0	0
Retained Earnings	87.89	586.20	507.96	417.68	338.31

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article